Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants
Clinical trial NCT00514709 · COMPLETED
Trial details
- NCT number
- NCT00514709
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-12-01
- Enrollment
- 1843
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.